Welcome to our dedicated page for Texas Instrument SEC filings (Ticker: TXN), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Texas Instruments Incorporated filings document operating results, governance actions, capital-structure details and material events for a Nasdaq-listed semiconductor company. Form 8-K reports cover quarterly and annual results, furnished earnings releases, non-GAAP free cash flow measures and related reconciliations, as well as dividend and shareholder-return disclosures.
Proxy and annual meeting filings describe board elections, executive compensation votes, auditor ratification and other stockholder proposals. Additional 8-K disclosures record by-law amendments, forum-selection provisions, officer transition matters, registered common stock details and exhibits filed in Inline XBRL.
Texas Instruments Sr. Vice President Ron Amichai reported an option exercise and share sale in the company’s common stock. He exercised stock options covering 15,865 shares at an exercise price of $104.41 per share, then completed an open-market sale of 18,365 shares at a weighted average price of $272.432 per share, with individual trades ranging from $272.075 to $272.99. Following these transactions, he holds 81,085 shares of Texas Instruments common stock directly, and the exercised non-qualified stock option for 15,865 shares is now fully used.
Texas Instruments director Mark A. Blinn reported trust-related stock sales in Texas Instruments Inc. common stock. Trusts associated with Blinn sold a total of 15,000 shares in open-market transactions at prices around $276–$279 per share. Following these transactions, Blinn directly holds 11,670 shares, while some trust positions are reduced or fully sold, and certain family trusts are reported with beneficial ownership disclaimed by Blinn.
Texas Instruments senior vice president and CFO Rafael R. Lizardi reported an option exercise and related stock sales. He exercised a non-qualified stock option for 40,541 shares of common stock at an exercise price of $169.23 per share, receiving common shares.
On the same date, he sold a total of 40,541 shares of common stock in open‑market transactions at weighted average prices of about $273.74, $274.70, and $275.53 per share, with actual sale prices ranging from $273.22 to $275.79. Following these transactions, he directly held 85,485 shares and indirectly held 33,994 shares through a SLAT.
Texas Instruments Inc. director Pamela H. Patsley reported an option exercise and share sale. On April 24, 2026, she exercised a nonqualified stock option for 4,306 shares of common stock at $110.15 per share and sold 4,306 shares in an open-market transaction.
The reported weighted average sale price was $276.1074 per share, with individual sale prices ranging from $275.925 to $276.48. After these transactions, Patsley directly held 34,487 shares of Texas Instruments common stock. The option exercised covered 4,306 underlying shares and was scheduled to vest in four equal annual installments beginning on January 25, 2019.
Texas Instruments senior vice president Christine Witzsche reported an exercise-and-sell transaction in company stock. On April 24, 2026, she sold 3,625 shares of common stock in an open-market sale at a weighted average price of $275.5229 per share, with individual trades ranging from $275.02 to $276.01.
On the same date, she exercised non-qualified stock options covering a total of 3,625 shares at exercise prices between $79.26 and $130.52 per share, fully exercising the reported option grants. After these transactions, she directly owns 25,617 Texas Instruments shares.
Texas Instruments submitted a Form 144 notifying the proposed sale of 6,125 shares of Common Stock through UBS Financial Services Inc for an aggregate amount of $1,656,283.36 with a proposed sale date of 04/27/2026.
The notice lists shares sourced from ESOP awards dated 01/24/2020 (1,100 shares) and 01/27/2022 (5,025 shares); proceeds are listed as cash.
Texas Instruments proposes resale of common shares via brokered cash transactions. The notice lists four blocks of common stock dated 01/25/2019, 01/24/2020, 01/28/2021, and 01/27/2022 totaling specified lot sizes; sale date on the form is 04/24/2026.
Texas Instruments reported a Form 144 notice of proposed sale of shares. The filing lists 40,541 shares of Common Stock associated with UBS Financial Services Inc. and identifies sales tied to an ESOP and RSU activity. The filing shows sales reported on 02/10/2026 and 02/11/2026 with a filing date of 04/24/2026.
UBS Financial Services Inc. submitted a Form 144 notice proposing the sale of 3,625 shares of common stock of Texas Instruments. The shares originate from ESOP grants dated 01/26/2017, 01/25/2018, 01/25/2019, and 01/24/2020. The filing lists a transaction date of 04/24/2026 and shows an aggregate value of $998,770.52. The sale method is described as cash and the broker listed is UBS Financial Services Inc.